EU Investigate Potential Suicide Risk From New Class Of Weight-Loss Drugs
The European Union's drugs regulator has asked pharma companies including Novo Nordisk A/S and Eli Lilly & Co. for more information as it reviews the potential risk of suicidal thoughts associated with a new class of weight-loss…
Read More...
Read More...